BR9908825A - Forma cristalina de paroxetina - Google Patents
Forma cristalina de paroxetinaInfo
- Publication number
- BR9908825A BR9908825A BR9908825-8A BR9908825A BR9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A BR 9908825 A BR9908825 A BR 9908825A
- Authority
- BR
- Brazil
- Prior art keywords
- paroxetine
- crystalline form
- free
- crystalline
- therapy
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 3
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 3
- 229960002296 paroxetine Drugs 0.000 title abstract 3
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"FORMA CRISTALINA DE PAROXETINA" Base livre de paroxetina pura, cristalina, por exemplo, e isenta de solvente; e o seu emprego na terapia para tratar depressão.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
| GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
| GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
| PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9908825A true BR9908825A (pt) | 2000-11-21 |
Family
ID=27269245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9908825-8A BR9908825A (pt) | 1998-03-16 | 1999-03-16 | Forma cristalina de paroxetina |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1064282A1 (pt) |
| JP (1) | JP2002506865A (pt) |
| KR (1) | KR20010041947A (pt) |
| CN (1) | CN1300286A (pt) |
| AP (1) | AP2000001907A0 (pt) |
| AU (1) | AU2847199A (pt) |
| BG (1) | BG104839A (pt) |
| BR (1) | BR9908825A (pt) |
| CA (1) | CA2323896A1 (pt) |
| EA (1) | EA200000946A1 (pt) |
| HU (1) | HUP0101215A3 (pt) |
| ID (1) | ID27596A (pt) |
| IL (1) | IL138390A0 (pt) |
| NO (1) | NO20004583L (pt) |
| PL (1) | PL342931A1 (pt) |
| SK (1) | SK13622000A3 (pt) |
| TR (1) | TR200002675T2 (pt) |
| WO (1) | WO1999047519A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
| US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| AR001982A1 (es) * | 1995-02-06 | 1998-01-07 | Smithkline Beecham Plc | Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion |
-
1999
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Application Discontinuation
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Application Discontinuation
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1064282A1 (en) | 2001-01-03 |
| BG104839A (en) | 2001-09-28 |
| HUP0101215A2 (hu) | 2002-04-29 |
| KR20010041947A (ko) | 2001-05-25 |
| TR200002675T2 (tr) | 2000-12-21 |
| EA200000946A1 (ru) | 2001-02-26 |
| NO20004583D0 (no) | 2000-09-14 |
| ID27596A (id) | 2001-04-12 |
| CA2323896A1 (en) | 1999-09-23 |
| CN1300286A (zh) | 2001-06-20 |
| PL342931A1 (en) | 2001-07-16 |
| AU2847199A (en) | 1999-10-11 |
| NO20004583L (no) | 2000-09-15 |
| IL138390A0 (en) | 2001-10-31 |
| AP2000001907A0 (en) | 2000-09-30 |
| JP2002506865A (ja) | 2002-03-05 |
| HUP0101215A3 (en) | 2002-05-28 |
| WO1999047519A1 (en) | 1999-09-23 |
| SK13622000A3 (sk) | 2001-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0014076A (pt) | Benzamidas e inibidores correlatos do fator xa | |
| BR0014384A (pt) | Compostos para o tratamento da isquémia | |
| DE69932183D1 (de) | ANWENDUNG VON ZIELGERICHTETEM RADIUM 223 FüR PALLIATIVE UND THERAPEUTISCHE BEHANDLUNG VON KNOCHENKREBS | |
| BR0014078A (pt) | Inibidores de fator xa | |
| BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
| BR0114576A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto | |
| BR9911682A (pt) | Metano sulfonato de paroxetina | |
| BR9813028A (pt) | Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos | |
| BR0111913A (pt) | Análogos de gabapentina para distúrbios do sono | |
| BR9912376A (pt) | Sais de nitrato, composições farmacêuticas, udo de sais e composições, e, processo para preparação de sais de nitrato. | |
| SE9802208D0 (sv) | Novel compounds | |
| ES2177316T3 (es) | Anticuerpos humanos antifacotores ix/ixa. | |
| BR0213072A (pt) | Sabonete em barra | |
| BR0208353A (pt) | Compostos de diidropirimidina substituìdos com ciano e seu uso para tratar doenças | |
| DE59813162D1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
| PT1030667E (pt) | Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono | |
| FI962550A0 (fi) | Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa | |
| BR9908825A (pt) | Forma cristalina de paroxetina | |
| TR200002203T2 (tr) | Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi. | |
| BR0313522A (pt) | Uso de oligonucleotìdeos anti-sentido para inibir a expressão de akt-1 | |
| ECSP034530A (es) | Derivados de 6-metil-tramadol sustituido en o | |
| ES2088877T3 (es) | Procedimiento de preparacion del 3-pirrolidinol. | |
| AP2000001937A0 (en) | Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway. | |
| BR9804769A (pt) | Processo para tratar ou prevenir infecção por pestivìrus em um hospedeiro mamìfero tendo ou sendo suscetìvel a referida infecção,e , para tratar c~elulas de mamìferos em cultura, e, em mamìferos biológicos | |
| UY26648A1 (es) | Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |